Updated: Nov 7
Earlier this week, the Lown Institute released finalists in its annual Shkreli Awards recognizing the ‘worst examples of profiteering and dysfunction in health care.’ The awards are named after Martin Shkreli, who dramatically and overwhelmingly raised the price of a decades-old drug by 5000% and quickly became known as the “pharma bro.”
Of note among this year’s nominees, the chief medical officer at Memorial Sloan Cancer Center, was found to have violated conflict of interest policies by not disclosing the millions of dollars that he had received from Big Pharma.
His ‘punishment’ was a high-level executive position within the Research and Development department at a Big Pharma company. In fact, it’s one of the cancer drug companies that previously had paid him for consulting work. Imagine that!
The other nominees are accused of equally egregious behavior, check the full list out at this link.